Pricing Market Research Reports & Industry Analysis
Pricing Industry Research & Market Reports
-
Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029
... 2029 The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. The market is ... Read More
-
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024–2029
... follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market landscapes across ... Read More
-
Pharmerging Market Size, Share & Trends Analysis Report By Product (Pharmaceutical, Healthcare), By Economy (Tier-1, Tier-2), By Indication (Lifestyle Disease, Infectious Disease), By Region, And Segment Forecasts, 2024 - 2030
... The global pharmerging market size is expected to reach USD 2.08 trillion in 2030 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This market is expected to grow due ... Read More
-
The 2025-2030 World Outlook for Vaccines Sales
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Cloud Computing in Healthcare Market by Product (Healthcare Payer Solutions, Healthcare Provider Solutions), Component (Services, Software), Pricing Model, SERVICE MODEL, Deployment Model - Global Forecast 2024-2030
... at USD 49.40 billion in 2023 and expected to reach USD 58.93 billion in 2024, at a CAGR 19.39% to reach USD 170.82 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 (Global Almanac)
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare ... Read More
-
Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal ... Read More
-
G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The G8 countries contributed $774.7 billion in 2022 to the global pharmaceuticals industry, ... Read More
-
North America (NAFTA) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement between ... Read More
-
BRIC Countries (Brazil, Russia, India, China) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are the ... Read More
-
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence
... continues to examine the impact of inflation on healthcare systems, patients, and HCPs. The report provides an overview of the current and future outlook of the healthcare sector, government policies, innovative technologies, and initiatives that ... Read More
-
Impact of Inflation on the Healthcare Sector - Analyzing Trends by Key Countries, Physicians and Healthcare Professionals (HCPs) Perspective, Patient Treatment and Treatment Costs
... not seen for several decades. Post-COVID-19 supply chain disruptions, strong consumer demand, and Russia's ongoing conflict with Ukraine are among the main factors contributing to increasing financial constraints on consumers and businesses, as well as ... Read More
-
Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) by Region - Overview of 2022 and Outlook for 2023
... forecasts from its Q1 2023 forecast cycle. The latest/global outlook for pricing and market access reforms in the pharmaceutical industry, including HTA reforms, IRP, clawbacks and much more. The report is powered by unique price ... Read More
-
Healthcare Expenditure and Pharmaceutical Sales by Region, Patent Expiries, New Technologies and Mergers and Acquisitions - Overview of 2022 and Outlook for 2023
... and pharmaceutical sales forecasts from its Q1 2023 forecast cycle. Global 10-year outlook for healthcare spend and pharmaceutical sales from GlobalData’s unique forecasting model. Provides key drivers and risks to outlook and includes the 2023 ... Read More
-
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022
... Database for the Indication COVID-19. Currently there are 52 drugs indicated for COVID-19 which have analyst consensus forecasts available. Scope This report gives important, expert insight you won’t find in any other source. 16 figures ... Read More
-
Vaccine Market Report 2022
... more than double to $83.5 billion by 2027. The U.S. alone is projected to reach $30 billion by 2027. Routine Vaccinations Continued To Lag In 2021. Pandemic-driven declines in routine vaccines persisted in 2021. Compared ... Read More
-
Healthcare Smart Contracts Market Size, Share & Trends Analysis Report By Blockchain Type (Ethereum, Hyperledger Fabric), By Application (Clinical Trials, Supply Chain Management), By End-use, By Region, And Segment Forecasts, 2022 - 2030
... is expected to expand at a CAGR of 20.5% from 2022 to 2030. Key benefits offered by technology such as decentralized management, data provenance, robust data, traceable data drives the market. Increasing businesses demand the ... Read More
-
The 2023-2028 World Outlook for Vaccines Sales
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Infosys and Top Pharma Bring Digital Transformation to Drug Manufacturing Data
... in biopharmaceutical manufacturing hold great potential for speeding lifesaving and life-improving drugs to manufacture while improving quality and efficiency. As pressure increases on drug companies to lower prices and costs, digital transformation in manufacturing data ... Read More
-
IDC Perspective: Real-World Evidence and Drug Pricing in 2022
... patients, private and government healthcare payers, life science companies, and society at large. "As life science companies, private and public healthcare payers, and healthcare providers learn to use RWE to discover the true value of ... Read More
-
Pharmacy Retail Market in India 2022
... of medicines. Consumers have improved access to medicines because of advanced medical infrastructure, launch of patented drugs. But factors such as low-profit margins, price control measures, and poor inventory management hinder market growth. Market insights: ... Read More
-
Japan Healthcare Review - Q1 2021
... FY 2021 budget, demonstrates a continued focus on confronting the COVID-19 crisis through strengthening financial support for private healthcare institutions and local municipal governments while driving rapid COVID-19 vaccinations through the first half of 2021. ... Read More
-
NASH Drug Pipeline and Market Overview
... of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment ... Read More
Research Assistance
